Visceral Fat as Target of Highly Active Antiretroviral Therapy-Associated Metabolic Syndrome

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|13|21|2208-2213

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.13, Iss.21, 2007-07, pp. : 2208-2213

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sex Differences in Antiretroviral Therapy-Associated Intolerance and Adverse Events

By Clark Rebecca  

Drug Safety, Vol. 28, Iss. 12, 2005-01 ,pp. : 1075-1083

Adis International

Access to resources Recommend Favorite

Morphological and Metabolic Components of Lipodystrophy in Various Nevirapine-Based Highly Active Antiretroviral Therapy (HAART) Regimens: A Cross-Sectional, Observational Study

By Guaraldi Giovanni  

Clinical Drug Investigation, Vol. 31, Iss. 11, 2011-11 ,pp. : 759-767

Adis International

Access to resources Recommend Favorite

Highly Active Antiretroviral Therapy: Pharmacoeconomic Issues in the Management of HIV Infection

By Sendi P.  

PharmacoEconomics, Vol. 19, Iss. 7, 2001-07 ,pp. : 709-713

Adis International

Access to resources Recommend Favorite

The role of pharmacological enhancement in protease inhibitor-based highly active antiretroviral therapy

By Becker Stephen L  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 3, 2003-03 ,pp. : 401-412

Informa Healthcare

Access to resources Recommend Favorite

Critical issues of HIV treatment in the era of highly active antiretroviral therapy

By Battegay M.  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 2, 2001-02 ,pp. : 175-183

Informa Healthcare

Access to resources Recommend Favorite